Oxford Optronix
@oxford-optronix.bsky.social
Founded in 1991, Oxford Optronix is a global pioneer in the design, development and manufacture of sophisticated instrumentation for the life sciences
Our goal is simple: To deliver thoughtfully designed, reliable products that exceed all expectations.
Our goal is simple: To deliver thoughtfully designed, reliable products that exceed all expectations.
Hi Prof. Garg,
Interesting letter to the editor here.
In most early preclinical and clinical studies using urine pO₂ as a renal-health marker (including those mentioned in your article), teams used our OxyLite to monitor urine O₂ in catheters. If your teams are exploring this, please reach out.
Interesting letter to the editor here.
In most early preclinical and clinical studies using urine pO₂ as a renal-health marker (including those mentioned in your article), teams used our OxyLite to monitor urine O₂ in catheters. If your teams are exploring this, please reach out.
September 17, 2025 at 1:57 PM
Hi Prof. Garg,
Interesting letter to the editor here.
In most early preclinical and clinical studies using urine pO₂ as a renal-health marker (including those mentioned in your article), teams used our OxyLite to monitor urine O₂ in catheters. If your teams are exploring this, please reach out.
Interesting letter to the editor here.
In most early preclinical and clinical studies using urine pO₂ as a renal-health marker (including those mentioned in your article), teams used our OxyLite to monitor urine O₂ in catheters. If your teams are exploring this, please reach out.